AGIONasdaqPharmaceutical PreparationsFiscal year ends December 31
AGIOS PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$34.90+3.58 (+11.43%)
Close on Oct 19, 2026
- Market cap
- $2.08B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Agios Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2026 | Jul 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 29, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 29, 2026 | Apr 29, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2026 | Apr 24, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 3, 2025 | Jul 8, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 18, 2025 | Apr 25, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2025 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 10, 2025 | Feb 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 3, 2025 | Jan 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 31, 2024 | Oct 31, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 1, 2024 | Aug 1, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2024 | Jun 20, 2024 | SEC EDGAR |
| Current report | 8-K | May 24, 2024 | May 28, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 2, 2024 | SEC EDGAR |
| Current report | 8-K | May 2, 2024 | May 2, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 20, 2024 | Apr 26, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 15, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 15, 2024 | Feb 15, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2024 | Jan 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 2, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 2, 2023 | Nov 2, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2023 | Aug 3, 2023 | SEC EDGAR |
| Current report | 8-K | Aug 3, 2023 | Aug 3, 2023 | SEC EDGAR |